Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Morris

Showing results (1371-1380 of 1,858) with videos related to

Pageof 186
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinomaMelanie B Thomas, Jeffrey S Morris, Romil Chadha, et al.
Trials|April 16, 2011
Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocolAnne B Chang, Keith Grimwood, Andrew V White, et al.
BMJ Open|December 23, 2021
Utility of a personalised <i>B</i>ronchiectasis <i>A</i>ction <i>M</i>anagement <i>P</i>lan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trialJulie M Marchant, Anne B Chang, Kobi L Schutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2022
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world dataM Pérol, E Felip, U Dafni, et al.
BMC Infectious Diseases|August 5, 2009
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001Amanda J Leach, Peter S Morris, Gabrielle B McCallum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
The American Journal of Clinical Nutrition|June 9, 2005
Carbohydrate intake and glycemic index in relation to the odds of early cortical and nuclear lens opacitiesChung-Jung Chiu, Martha S Morris, Gail Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune responseP Lu, X D Zhou, S J Chen, et al.
Lancet (London, England)|July 16, 1983
Prediagnostic serum selenium and risk of cancerW C Willett, B F Polk, J S Morris, et al.
The Cochrane Database of Systematic Reviews|June 8, 2025
Topical antiseptics for chronic suppurative otitis mediaKaren Head, Lee Yee Chong, Mahmood F Bhutta, et al.
Pageof 186

Showing results (1371-1380 of 1,858) with videos related to

Sort By:
Pageof 186
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinomaMelanie B Thomas, Jeffrey S Morris, Romil Chadha, et al.
Trials|April 16, 2011
Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocolAnne B Chang, Keith Grimwood, Andrew V White, et al.
BMJ Open|December 23, 2021
Utility of a personalised <i>B</i>ronchiectasis <i>A</i>ction <i>M</i>anagement <i>P</i>lan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trialJulie M Marchant, Anne B Chang, Kobi L Schutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2022
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world dataM Pérol, E Felip, U Dafni, et al.
BMC Infectious Diseases|August 5, 2009
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001Amanda J Leach, Peter S Morris, Gabrielle B McCallum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
The American Journal of Clinical Nutrition|June 9, 2005
Carbohydrate intake and glycemic index in relation to the odds of early cortical and nuclear lens opacitiesChung-Jung Chiu, Martha S Morris, Gail Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune responseP Lu, X D Zhou, S J Chen, et al.
Lancet (London, England)|July 16, 1983
Prediagnostic serum selenium and risk of cancerW C Willett, B F Polk, J S Morris, et al.
The Cochrane Database of Systematic Reviews|June 8, 2025
Topical antiseptics for chronic suppurative otitis mediaKaren Head, Lee Yee Chong, Mahmood F Bhutta, et al.
Pageof 186